KMT2A and acute myeloid leukemia: Furthermore, MAP7high was found in CN-AML (n = 116) among the different subgroups of AML patients as follows: 19 CBFβ-MYH11 patients, 10 patients with complex karyotypes, 17 patients with MLL-translocation, 86 patients with other findings, 18 PML-RARA patients, and 22 AML-ETO patients.